Tobias V Lanz Selected Research

Tobias V Lanz Research Topics

4	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 09/2009
4	Multiple Sclerosis 01/2020 - 05/2010
4	Neuroinflammatory Diseases 10/2019 - 09/2013
3	Inflammation (Inflammations) 10/2020 - 08/2010
3	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2017 - 05/2010
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022 - 01/2020
2	Infections 10/2020 - 07/2014
2	Neoplasms (Cancer) 12/2019 - 09/2013
1	Rheumatoid Arthritis 01/2022
1	Immunoglobulin G4-Related Disease 01/2022
1	Demyelinating Diseases (Demyelinating Disease) 01/2022
1	Hypoxia (Hypoxemia) 01/2021
1	Hallucinations (Hallucination) 01/2021
1	Hepatitis 10/2020
1	Virus Diseases (Viral Diseases) 10/2020
1	Glioma (Gliomas) 12/2013
1	Herpes Zoster 09/2013
1	Encephalitis (Encephalitis, Rasmussen) 08/2010
1	Paralysis (Palsy) 08/2010

4	Tryptophan (L-Tryptophan)FDA Link 01/2021 - 01/2017
3	AutoantibodiesIBA 01/2022 - 01/2020
2	KynurenineIBA 10/2020 - 01/2017
2	AntigensIBA 01/2020 - 01/2017
1	Immunoglobulin G (IgG)IBA 01/2022
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2022
1	Myelin-Associated GlycoproteinIBA 01/2022
1	AutoantigensIBA 01/2022
1	Caseins (Casein)FDA Link 01/2022
1	tryptamineIBA 01/2021
1	oxalylglycineIBA 01/2021
1	Hallucinogens (Psychedelics)IBA 01/2021
1	Tryptamines (Triptans)IBA 01/2021
1	Interferon Type IIBA 10/2020
1	Cell Surface ReceptorsIBA 12/2019
1	Essential Amino AcidsIBA 10/2019
1	Phosphotransferases (Kinase)IBA 01/2016
1	EndotoxinsIBA 07/2014
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 07/2014
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 12/2013
1	Protein Kinases (Protein Kinase)IBA 09/2013
1	Claudin-5IBA 09/2013
1	bisindolylmaleimideIBA 09/2013
1	Claudin-3IBA 09/2013
1	Transforming Growth Factor beta (TGF-beta)IBA 08/2010
1	Thrombospondin 1IBA 08/2010
1	Angiotensin IIIBA 08/2010
1	methionylmethylsulfonium chloride (MMSC)IBA 05/2010
1	Pharmaceutical PreparationsIBA 09/2009

2	Therapeutics 12/2019 - 05/2010